Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingShort-Term Debt repayments
Ratios

China Pharma Holdings (CPHI) Short-Term Debt issuances (2016 - 2023)

Historic Short-Term Debt issuances for China Pharma Holdings (CPHI) over the last 4 years, with Q4 2023 value amounting to $1.0 million.

  • China Pharma Holdings' Short-Term Debt issuances changed N/A to $1.0 million in Q4 2023 from the same period last year, while for Dec 2024 it was $1.0 million, marking a year-over-year decrease of 3295.75%. This contributed to the annual value of $492761.0 for FY2024, which is 6784.85% down from last year.
  • As of Q4 2023, China Pharma Holdings' Short-Term Debt issuances stood at $1.0 million.
  • In the past 5 years, China Pharma Holdings' Short-Term Debt issuances ranged from a high of $3.0 million in Q3 2021 and a low of -$6171.0 during Q3 2023
  • In the last 3 years, China Pharma Holdings' Short-Term Debt issuances had a median value of $336052.0 in 2020 and averaged $690606.6.
  • Over the last 5 years, China Pharma Holdings' Short-Term Debt issuances had its largest YoY gain of 29266.28% in 2021, and its largest YoY loss of 9267.61% in 2021.
  • China Pharma Holdings' Short-Term Debt issuances (Quarter) stood at $160979.0 in 2020, then tumbled by 92.68% to $11790.0 in 2021, then soared by 8667.42% to $1.0 million in 2023.
  • Its Short-Term Debt issuances stands at $1.0 million for Q4 2023, versus -$6171.0 for Q3 2023 and -$6011.0 for Q2 2023.